These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. [EXPERIENCES WITH OSPOLOT IN THE TREATMENT OF INFANTILE EPILEPSY]. DOOSE H, KLUGE D, EHMSEN U. Med Klin; 1964 Feb 14; 59():271-4. PubMed ID: 14135761 [No Abstract] [Full Text] [Related]
36. Factors associated with tonic-clonic seizures in patients with drug-resistant mesial temporal epilepsy. Asadi-Pooya AA, Rostami C, Rabiei AH, Sperling MR. J Neurol Sci; 2015 Dec 15; 359(1-2):452-4. PubMed ID: 26490320 [Abstract] [Full Text] [Related]
37. SULTHIAME (OSPOLOT) IN THE TREATMENT OF EPILEPSY. GORDON N. Dev Med Child Neurol; 1964 Apr 15; 6():195-6. PubMed ID: 14141745 [No Abstract] [Full Text] [Related]
38. CLINICAL EVALUATION OF A NEW ANTI-CONVULSANT, G.32883. DAVIS E. Med J Aust; 1964 Feb 01; 1():150-2. PubMed ID: 14118201 [No Abstract] [Full Text] [Related]
39. History and seizure semiology in distinguishing frontal lobe seizures and temporal lobe seizures. O'Brien TJ, Mosewich RK, Britton JW, Cascino GD, So EL. Epilepsy Res; 2008 Dec 01; 82(2-3):177-82. PubMed ID: 18804957 [Abstract] [Full Text] [Related]
40. [Assessment of personality traits in temporal lobe epilepsy and other forms of epilepsy with grand mal seizures]. Jakubowska T, Ostaszewska J, Kahl-Kunstetter J. Neurol Neurochir Pol; 1972 Dec 01; 6(5):841-6. PubMed ID: 4632368 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]